MODIV INDUSTRIAL INC (MDV) Fundamental Analysis & Valuation

NYSE:MDV • US60784B1017

14.97 USD
-0.33 (-2.16%)
At close: Mar 5, 2026
14.97 USD
0 (0%)
After Hours: 3/5/2026, 6:30:00 PM

This MDV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

MDV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. MDV has an average financial health and profitability rating. MDV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. MDV Profitability Analysis

1.1 Basic Checks

  • MDV had positive earnings in the past year.
  • In the past year MDV had a positive cash flow from operations.
  • In the past 5 years MDV reported 4 times negative net income.
  • In the past 5 years MDV always reported a positive cash flow from operatings.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • MDV has a worse Return On Assets (-0.54%) than 65.57% of its industry peers.
  • Looking at the Return On Equity, with a value of -1.63%, MDV is doing worse than 65.57% of the companies in the same industry.
  • MDV's Return On Invested Capital of 3.21% is fine compared to the rest of the industry. MDV outperforms 61.48% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MDV is in line with the industry average of 3.10%.
  • The last Return On Invested Capital (3.21%) for MDV is above the 3 year average (2.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.54%
ROE -1.63%
ROIC 3.21%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • The Operating Margin of MDV (42.50%) is better than 88.52% of its industry peers.
  • MDV's Operating Margin has improved in the last couple of years.
  • MDV's Gross Margin of 92.56% is amongst the best of the industry. MDV outperforms 94.26% of its industry peers.
  • MDV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 42.5%
PM (TTM) N/A
GM 92.56%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. MDV Health Analysis

2.1 Basic Checks

  • MDV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, MDV has more shares outstanding
  • The number of shares outstanding for MDV has been increased compared to 5 years ago.
  • The debt/assets ratio for MDV is higher compared to a year ago.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 0.10, we must say that MDV is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.10, MDV is doing worse than 72.95% of the companies in the same industry.
  • The Debt to FCF ratio of MDV is 17.98, which is on the high side as it means it would take MDV, 17.98 years of fcf income to pay off all of its debts.
  • MDV has a Debt to FCF ratio of 17.98. This is in the better half of the industry: MDV outperforms 78.69% of its industry peers.
  • A Debt/Equity ratio of 1.70 is on the high side and indicates that MDV has dependencies on debt financing.
  • MDV's Debt to Equity ratio of 1.70 is on the low side compared to the rest of the industry. MDV is outperformed by 66.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 17.98
Altman-Z 0.1
ROIC/WACC0.5
WACC6.38%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 4.25 indicates that MDV has no problem at all paying its short term obligations.
  • MDV's Current ratio of 4.25 is amongst the best of the industry. MDV outperforms 97.54% of its industry peers.
  • MDV has a Quick Ratio of 4.25. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
  • MDV's Quick ratio of 4.25 is amongst the best of the industry. MDV outperforms 97.54% of its industry peers.
Industry RankSector Rank
Current Ratio 4.25
Quick Ratio 4.25
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. MDV Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 157.14% over the past year.
  • Looking at the last year, MDV shows a decrease in Revenue. The Revenue has decreased by -0.59% in the last year.
  • Measured over the past years, MDV shows a quite strong growth in Revenue. The Revenue has been growing by 13.76% on average per year.
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%0.27%

3.2 Future

  • MDV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.95% yearly.
  • MDV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.05% yearly.
EPS Next Y-174.07%
EPS Next 2Y-25.69%
EPS Next 3Y22.95%
EPS Next 5YN/A
Revenue Next Year0.59%
Revenue Next 2Y0.65%
Revenue Next 3Y2.54%
Revenue Next 5Y1.05%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

3

4. MDV Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 93.56 indicates a quite expensive valuation of MDV.
  • Compared to the rest of the industry, the Price/Earnings ratio of MDV is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 26.74, MDV is valued quite expensively.
  • A Price/Forward Earnings ratio of 108.45 indicates a quite expensive valuation of MDV.
  • MDV's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.82, MDV is valued quite expensively.
Industry RankSector Rank
PE 93.56
Fwd PE 108.45
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MDV is valued a bit cheaper than the industry average as 74.59% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDV indicates a rather cheap valuation: MDV is cheaper than 90.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.88
EV/EBITDA 11.78
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MDV's earnings are expected to grow with 22.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.69%
EPS Next 3Y22.95%

4

5. MDV Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.60%, MDV is a good candidate for dividend investing.
  • MDV's Dividend Yield is a higher than the industry average which is at 7.03.
  • MDV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 7.6%

5.2 History

  • MDV has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of MDV decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • MDV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-551.99%
EPS Next 2Y-25.69%
EPS Next 3Y22.95%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

MDV Fundamentals: All Metrics, Ratios and Statistics

MODIV INDUSTRIAL INC

NYSE:MDV (3/5/2026, 6:30:00 PM)

After market: 14.97 0 (0%)

14.97

-0.33 (-2.16%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-14
Earnings (Next)03-10
Inst Owners23.02%
Inst Owner Change3.13%
Ins Owners3.04%
Ins Owner Change1.47%
Market Cap153.74M
Revenue(TTM)47.04M
Net Income(TTM)-2.68M
Analysts82.22
Price Target18.11 (20.98%)
Short Float %2.55%
Short Ratio5.86
Dividend
Industry RankSector Rank
Dividend Yield 7.6%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-551.99%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)65.02%
Min EPS beat(2)-100%
Max EPS beat(2)230.03%
EPS beat(4)3
Avg EPS beat(4)104.41%
Min EPS beat(4)-100%
Max EPS beat(4)230.03%
EPS beat(8)5
Avg EPS beat(8)-93.26%
EPS beat(12)7
Avg EPS beat(12)26.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-1.65%
Max Revenue beat(2)-1.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-1.65%
Max Revenue beat(4)1.93%
Revenue beat(8)2
Avg Revenue beat(8)-1.17%
Revenue beat(12)5
Avg Revenue beat(12)3.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.95%
PT rev (3m)0%
EPS NQ rev (1m)19.35%
EPS NQ rev (3m)-0.89%
EPS NY rev (1m)3.51%
EPS NY rev (3m)-92.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE 93.56
Fwd PE 108.45
P/S 3.27
P/FCF 9.88
P/OCF 9.53
P/B 0.93
P/tB 0.94
EV/EBITDA 11.78
EPS(TTM)0.16
EY1.07%
EPS(NY)0.14
Fwd EY0.92%
FCF(TTM)1.52
FCFY10.12%
OCF(TTM)1.57
OCFY10.49%
SpS4.58
BVpS16.05
TBVpS15.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.6
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -1.63%
ROCE 4.06%
ROIC 3.21%
ROICexc 3.27%
ROICexgc 3.28%
OM 42.5%
PM (TTM) N/A
GM 92.56%
FCFM 33.08%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexgc growth 3Y59.93%
ROICexgc growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 17.98
Debt/EBITDA 7.69
Cap/Depr 3.44%
Cap/Sales 1.2%
Interest Coverage 1.51
Cash Conversion 44.32%
Profit Quality N/A
Current Ratio 4.25
Quick Ratio 4.25
Altman-Z 0.1
F-Score4
WACC6.38%
ROIC/WACC0.5
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-174.07%
EPS Next 2Y-25.69%
EPS Next 3Y22.95%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%0.27%
Revenue Next Year0.59%
Revenue Next 2Y0.65%
Revenue Next 3Y2.54%
Revenue Next 5Y1.05%
EBIT growth 1Y11.55%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year79.56%
EBIT Next 3Y25.25%
EBIT Next 5Y15.97%
FCF growth 1Y114.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.97%
OCF growth 3Y23.3%
OCF growth 5Y30.88%

MODIV INDUSTRIAL INC / MDV FAQ

Can you provide the ChartMill fundamental rating for MODIV INDUSTRIAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to MDV.


What is the valuation status of MODIV INDUSTRIAL INC (MDV) stock?

ChartMill assigns a valuation rating of 3 / 10 to MODIV INDUSTRIAL INC (MDV). This can be considered as Overvalued.


What is the profitability of MDV stock?

MODIV INDUSTRIAL INC (MDV) has a profitability rating of 5 / 10.


What is the valuation of MODIV INDUSTRIAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MODIV INDUSTRIAL INC (MDV) is 93.56 and the Price/Book (PB) ratio is 0.93.


What is the financial health of MODIV INDUSTRIAL INC (MDV) stock?

The financial health rating of MODIV INDUSTRIAL INC (MDV) is 4 / 10.